Askbio Inc

This study tests a single dose of AB-1002, a gene therapy given directly into the heart's arteries, for people with advanced heart failure (NYHA Class III) caused by non-ischemic cardiomyopathy. About 150 adults will be randomly assigned to receive the therapy or a placebo. The g…

This study follows 150 people with early Parkinson's disease or Multiple System Atrophy (MSA) for up to 18 months. Researchers measure changes in movement, daily living, and quality of life to better understand how these conditions progress. The goal is to gather detailed informa…

This study follows 132 people with Parkinson's disease or multiple system atrophy who previously received AB-1005 gene therapy. Researchers will track safety and how well the treatment works over time. Participants are simply observed, with no new treatments given.